TP53 and diffuse large B-cell lymphoma: Because SIRT1, 2 and 3 as well as p53 also regulate the expression of LC3B-II [25–30], we investigated whether they might mediate LC3B-II increase in DLBCL cells following tenovin-6 treatment.